Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10072-020-04636-7.pdf
Reference19 articles.
1. Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52:1331–1340. https://doi.org/10.1111/j.1528-1167.2011.03109
2. Rogawski MA, Hanada T (2013) Preclinical pharmacology of perampanel, a selective non- competitive AMPA receptor antagonist. Acta Neurol Scand Suppl 127:19–24. https://doi.org/10.1111/ane.12100
3. Villanueva V, Montoya J, Castillo A, Mauri-Llerda JÁA, Giner P, Lóopez-GonzÁalez FJ et al (2018) Perampanel in routine clinical use in idiopathic generalized epilepsy: the 12- month GENERAL study. Epilepsia 59:1740–1752. https://doi.org/10.1111/epi.14522
4. Nishida T, Lee SK, Inoue Y, Saeki K, Ishikawa K, Kaneko S (2018) Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study. Acta Neurol Scand 137:392–399. https://doi.org/10.1111/ane.12883
5. French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA (2012 Aug 7) Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 79(6):589–596. https://doi.org/10.1212/WNL.0b013e3182635735
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and tolerability of perampanel: a Chinese real-world observational study in epilepsy;Frontiers in Neurology;2024-01-19
2. Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study;Journal of the Neurological Sciences;2023-12
3. Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study;Epilepsy & Behavior;2023-10
4. The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy;Frontiers in Neurology;2023-07-06
5. Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study;Frontiers in Neurology;2023-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3